General Information of the Compound
| Compound ID |
CP0787091
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CO-102862
Show/Hide
|
||||||||||||||||||
| Synonyms |
(E)-2-(4-(4-fluorophenoxy)benz-ylidene)hydrazinecarboxamide
0KN11H90GF
181144-66-1
2-((4-(4-Fluorophenoxy)phenyl)methylene)hydrazinecarboxamide
2-(4-(4-Fluorophenoxy)benzylidene)hydrazinecarboxamide
2-[[4-(4-Fluorophenoxy)phenyl]methylene]hydrazinecarboxamide
4-(4-fluorophenoxy)benzaldehyde semicarbazone
AKOS016004881
BDBM50141073
CHEBI:92156
CHEMBL287833
CO 102862
CO-102862
Hydrazinecarboxamide, 2-((4-(4-fluorophenoxy)phenyl)methylene)-
MolPort-022-863-701
NCGC00167807-01
UNII-0KN11H90GF
V-102862
V102862
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H12FN3O2
|
||||||||||||||||||
| Molecular Weight |
273.267
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)N/N=C/c1ccc(Oc2ccc(F)cc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H12FN3O2/c15-11-3-7-13(8-4-11)20-12-5-1-10(2-6-12)9-17-18-14(16)19/h1-9H,(H3,16,18,19)/b17-9+
Show/Hide
|
||||||||||||||||||
| InChIKey |
MHUUDVZSPFRUSK-RQZCQDPDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound